FAIRY: A randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Reim, Daniel ^a,b   Kim, Young Woo ^a   Nam, Byung H ^a   Kim, Mi Jung ^a   Yook, Jeong H ^d   Park, Young K ^e   Roh, Sung H ^f   Yu, Wan S ^g   Bae, Jae M ^c  

^a National Cancer Center   (South Korea)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Asan Medical Center   (South Korea)

^e Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

Author keywords

Ferric carboxymaltose; Gastric cancer; Isovolemic postoperative anemia; Randomized controlled trial

Indexed keywords

FERRIC CARBOXYMALTOSE; HEMOGLOBIN; PLACEBO;

ACUTE ISOVOLEMIC ANEMIA; ANEMIA; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GASTRECTOMY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH CANCER; TREATMENT DURATION;

ANEMIA; BIOLOGICAL MARKERS; BLOOD VOLUME; CLINICAL PROTOCOLS; FEMALE; FERRIC COMPOUNDS; GASTRECTOMY; HEMATINICS; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MALTOSE; QUALITY OF LIFE; REPUBLIC OF KOREA; RESEARCH DESIGN; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899486629     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-111     Document Type: Article

References (25)

1. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004, Suppl 7A:58S-69S.
2. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007, 47:1468-1480. 10.1111/j.1537-2995.2007.01286.x, 17655591.
3. Weiskopf RB, Kramer JH, Viele M, Neumann M, Feiner JR, Watson JJ, Hopf HW, Toy P. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000, 92:1646-1652. 10.1097/00000542-200006000-00023, 10839915.
4. Weiskopf RB, Feiner J, Hopf HW, Viele MK, Watson JJ, Kramer JH, Ho R, Toy P. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002, 96:871-877. 10.1097/00000542-200204000-00014, 11964594.
5. Jung DH, Lee HJ, Han DS, Suh YS, Kong SH, Lee KU, Yang HK. Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery. Gastric Cancer 2013, 16:377-382. 10.1007/s10120-012-0196-8, 23007652.
6. Liang YX, Guo HH, Deng JY, Wang BG, Ding XW, Wang XN, Zhang L, Liang H. Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol 2013, 19:5542-5550. 10.3748/wjg.v19.i33.5542, 3761109, 24023499.
7. Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K. Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J Am Coll Surg 1997, 184:240-244.
8. Weber RS, Jabbour N, Martin RC. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008, 15:34-45. 10.1245/s10434-007-9502-9, 17943390.
9. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med 2007, 131:708-718.
10. Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988, 6:1348-1354.
11. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006, 1. CD005033.
12. Kneuertz PJ, Patel SH, Chu CK, Maithel SK, Sarmiento JM, Delman KA, Staley CA, Kooby DA. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 2011, 18:1327-1334. 10.1245/s10434-010-1476-3, 21369744.
13. Wang CC, Iyer SG, Low JK, Lin CY, Wang SH, Lu SN, Chen CL. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009, 16:1832-1842. 10.1245/s10434-009-0448-y, 19365625.
14. Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant 2011, 26:1599-1607. 10.1093/ndt/gfq613, 3084440, 20929915.
15. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M, . Anaemia Working Group España A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patientsundergoing major elective surgery. Br J Anaesth 2011, 107:477-478. 10.1093/bja/aer242, 21841061, Anaemia Working Group España.
16. Yoon HM, Kim YW, Nam BH, Reim D, Eom BW, Park JY, Ryu KW. Intravenous iron supplementation may be superior to observation in acute isovolemic post-gastrectomy anemia. World J Gastroenterol 2014, 20:1582-1857. 10.3748/wjg.v20.i6.1582, 3925867, 24587634.
17. Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002, 95:888-895. 10.1002/cncr.10763, 12209734.
18. UICC TNM classification of malignant tumours 2010, New York, NY: Wiley-Liss, Sobin LH, Wittekind C, 7, UICC.
19. Pocock SJ. Clinical trials: a practical approach 1983, New York: John Wiley & Sons Ltd.
20. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, . American Society of Clinical Oncology; American Society of Hematology American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010, 28:4996-5010. 10.1200/JCO.2010.29.2201, 20975064, American Society of Clinical Oncology; American Society of Hematology.
21. Evstatiev R, Marteau P, Iqbal T, . FERGI Study Group FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011, 141:846-853. 10.1053/j.gastro.2011.06.005, 21699794, FERGI Study Group.
22. Lim CH, Kim SW, Kim WC, Kim JS, Cho YK, Park JM, Lee IS, Choi MG, Song KY, Jeon HM, Park CH. Anemia after gastrectomy for early gastric cancer: long-term follow-up observational study. World J Gastroenterol 2012, 18:6114-6119. 10.3748/wjg.v18.i42.6114, 3496888, 23155340.
23. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, . FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361:2436-2448. 10.1056/NEJMoa0908355, 19920054, FAIR-HF Trial Investigators.
24. Pfenniger A, Schuller C, Christoph P, Surbek D. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia. J Perinat Med 2012, 40:397-402.
25. Park SH, Nam E, Bang SM, Cho EK, Shin DB, Lee JH. A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer. Cancer Chemother Pharmacol 2008, 62:1-9. 10.1007/s00280-007-0561-1, 17690882.